Navigation Links
Quitting Smoking Made Easy By Track Of New Chemical

A new study has been designed to help researchers track a tracer chemical, monamine oxidase (MAO), which will help those struggling to quit smoking. This enzyme has been found to play a crucial role in blood pressure and mood regulation // has two subtypes MAO A and B.

The study showed that levels of MAO B in smokers' peripheral organs - the heart, kidneys, spleen and lungs - were reduced by 40 to 50 percent compared to non-smokers.

The results of tracking [MAO] A showed that is fairly well intact in all of the organs but the lungs. The levels in smokers were 50 percent lower than in non-smokers, and also smokers held onto the tracer much longer than non-smokers.

It means, for example... that your lungs are going to retain nicotine, that you're going to have a lower level of nicotine in your bloodstream than say a non-smoker, someone just starting out smoking.

So here's where smokers need to pay attention: lower blood concentration in smokers' lungs, as evidenced by their holding onto the enzyme-binding tracer, could be a possible factor behind why you eventually need to smoke more to get the same effect.

This new finding could be the basis of better treatments to quit smoking in the future.

Source: Indo-Asian News Service
'"/>




Page: 1

Related medicine news :

1. Quitting smoking stops lung decline
2. Quitting the smoking habit
3. Women Benefit More from Quitting Smoking than Men
4. Quitting Psychotherapy Midway May Be Preventable
5. Taylor & Campbell Quitting NHS
6. Taylor & Campbell Quitting NHS
7. Smokers are Prone to Weight Gain After Quitting
8. Save your Vision with Fish Oil and Quitting Smoking
9. Women Smokers Fear Quitting Will Lead to Weight Gain
10. For Smokers Only: is Quitting = Cutting Down?? a grave Issue
11. Exercise can Reduce Smokers Lung Cancer Risk but the Most Important is Quitting Smoking – a Study Report
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids ... Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, ... run is geared towards children of all ages; it is a non-competitive, non-timed event, ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a ... “The Journey: From the Mountains to the Mission Field” is the creation of published ... all ages and currently teaches a class of ladies at her church, which she ...
(Date:10/12/2017)... LA (PRWEB) , ... October 12, 2017 , ... Planet ... in the U.S., announced today its plans to open a flagship location in Covington, ... occupy the former Rooms To Go store next to Office Depot in the Holiday ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a ... health care, have expanded their existing home health joint venture through an agreement, ... been operating a joint venture home health company with Asante, delivering clinically integrated ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... Leading ... their peers in Washington, D.C., for the 49th Congress of the International Society ... ., Vice President of the Center for Cancer and Blood Disorders at ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), will ... and webcast on Friday, November 3, 2017, beginning at ... at approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... financial performance and guidance for 2018, Hill-Rom executives will ... operational performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... today announced that its MyDario product is expected to appear on The ... when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz ... The ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
Breaking Medicine Technology: